ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,187.67
0.00%
Dow Jones
39,056.39
0.44%
US Dollar vs MXN
16.9189
0.07%
Brent Oil
83.56
0.84%
Bitcoin
61,061.11
-2.04%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Abbott Laboratories (ABT)

  7. Abbott Laboratories (ABT) Noticias

ABT

Abbott Laboratories (ABT)

Abbott Laboratories
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NYSE:ABT
FechaHoraFuenteTítuloSímboloCompañía
08/05/202416:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:ABTAbbott Laboratories
07/05/202417:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:ABTAbbott Laboratories
29/04/202408:00PR Newswire (US)Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the KneeNYSE:ABTAbbott Laboratories
17/04/202410:37IH Market NewsAbbott Laboratories Reports Strong Q1 Sales Growth Amid Earnings Decline, Raises Full-Year GuidanceNYSE:ABTAbbott Laboratories
17/04/202406:30PR Newswire (US)Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance RangesNYSE:ABTAbbott Laboratories
17/04/202405:59IH Market NewsUS Index Futures See Gains, Oil Prices DipNYSE:ABTAbbott Laboratories
03/04/202406:12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:ABTAbbott Laboratories
02/04/202408:00PR Newswire (US)Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
01/04/202408:00PR Newswire (US)Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's BedsideNYSE:ABTAbbott Laboratories
27/03/202415:30PR Newswire (US)Abbott Hosts Conference Call for First-Quarter EarningsNYSE:ABTAbbott Laboratories
19/03/202407:00PR Newswire (Canada)Canadian First - Abbott Advances Chronic Pain Management with the World's Smallest Implanted, Rechargeable Spinal Cord Stimulation SystemNYSE:ABTAbbott Laboratories
19/03/202407:00PR Newswire (Canada)Une première au Canada -- Abbott fait progresser le traitement de la douleur chronique grâce au plus petit système de stimulation de la moelle épinière implantée et rechargeable au mondeNYSE:ABTAbbott Laboratories
06/03/202408:00PR Newswire (US)Real-World Data Show Abbott's FreeStyle Libre® Systems and GLP-1 Medicines Work Better Together for People with Type 2 DiabetesNYSE:ABTAbbott Laboratories
16/02/202415:15Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NYSE:ABTAbbott Laboratories
16/02/202409:19PR Newswire (US)Abbott Declares 401st Consecutive Quarterly DividendNYSE:ABTAbbott Laboratories
13/02/202417:47PR Newswire (US)FDA Advisory Committee Votes in Favor of Abbott's First-of-Its-Kind TriClip™ System to Treat People With a Leaky Tricuspid Heart ValveNYSE:ABTAbbott Laboratories
13/02/202415:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:ABTAbbott Laboratories
05/02/202404:31IH Market NewsSantander’s Stock Declines Amid Sanctions Evasion Scandal, Boeing 737 MAX Delivery Challenges, and MoreNYSE:ABTAbbott Laboratories
01/02/202408:00PR Newswire (US)New Study Shows Mixed Reality Technology for Blood Donation from Abbott and Blood Centers of America Helps Ease Stress, Encourages People to Donate AgainNYSE:ABTAbbott Laboratories
31/01/202408:00PR Newswire (US)Abbott Launches New PROTALITY™ Brand to Support Adults on Their Weight Loss JourneyNYSE:ABTAbbott Laboratories
29/01/202415:10Edgar (US Regulatory)Form 8-K - Current reportNYSE:ABTAbbott Laboratories
25/01/202408:00PR Newswire (US)Abbott Launches World's Smallest Rechargeable System With Remote Programming Capabilities to Treat Movement Disorders¹+NYSE:ABTAbbott Laboratories
25/01/202405:25IH Market NewsWall Street Highlights: Nokia’s Margins Surprise, FAA Halts Boeing Production Expansion, and MoreNYSE:ABTAbbott Laboratories
24/01/202407:19Dow Jones NewsAbbott Labs Posts Higher 4Q Sales, Despite Soft Demand For Covid TestsNYSE:ABTAbbott Laboratories
24/01/202406:30PR Newswire (US)Abbott Reports Fourth-Quarter and Full-Year 2023 Results; Issues 2024 Financial OutlookNYSE:ABTAbbott Laboratories
24/01/202405:06IH Market NewsWall Street Highlights: eBay Slashes 9% of Workforce, SAP to Reduce 8,000 Positions, and MoreNYSE:ABTAbbott Laboratories
18/01/202408:48Dow Jones NewsAbbott's Volt PFA System Used in Procedures for Patients with Abnormal Heart RhytmsNYSE:ABTAbbott Laboratories
18/01/202408:00PR Newswire (US)Abbott Announces First Global Procedures in a Clinical Trial of its Volt™ Pulsed Field Ablation System to Treat Patients with Abnormal Heart RhythmsNYSE:ABTAbbott Laboratories
08/01/202407:00Business WireTandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus SensorNYSE:ABTAbbott Laboratories
03/01/202408:00PR Newswire (US)Abbott Hosts Conference Call for Fourth-Quarter EarningsNYSE:ABTAbbott Laboratories
 Showing the most relevant articles for your search:NYSE:ABT

Su Consulta Reciente

NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
NVDA
NVIDIA
USOTC
BNPQY
BNP Paribas (QX)
NYSE
NKE
Nike
CCOM
US30
US 30
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
AMEX
XLE
Energy Select Sector SPDR
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
FX
USDMXN
US Dollar vs MXN
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados